PubMed:32338224 / 2587-2791 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T111 95-103 SP_7 denotes COVID-19
T112 128-133 SP_6 denotes human
T113 128-133 NCBITaxon:9606 denotes human
T114 128-138 PG_10 denotes human ACE2
T115 134-138 PR:000003622 denotes ACE2

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T11 95-103 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T52 41-42 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T53 128-133 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T16 0-204 DRI_Challenge denotes Furthermore, same authors predicted that a single mutation at the 501 position may enhance the COVID-19 RBD binding capacity to human ACE2 and this evolution should be monitored in infected patients [14].

LitCovid_AGAC_only

Id Subject Object Predicate Lexical cue
p11099s14 83-90 PosReg denotes enhance
p11099s16 95-100 Protein denotes COVID
p11099s17 100-101 Protein denotes -
p11099s18 101-107 Protein denotes 19 RBD
p11099s20 108-124 MPA denotes binding capacity
p11099s24 134-138 Protein denotes ACE2

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T16 0-204 Sentence denotes Furthermore, same authors predicted that a single mutation at the 501 position may enhance the COVID-19 RBD binding capacity to human ACE2 and this evolution should be monitored in infected patients [14].